NEW MEMBER SIGN UP
  Display Name
 
  Email Address
 
  Password
 
  Password again
 
  Zip
 
Country
 
   

Close Window

Privacy Statement
BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
     
Community Login

What is this?
Biotechnology and Pharmaceutical ChannelMedical Device and Diagnostics ChannelClinical Research Channel Employers
 Post Job | Search Resumes | Login

NEWSLETTERS
Free Newsletters
Archive
My eNewsletters

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

COMMUNITY
Login
Become a Member
Discussion Forums
FAQ

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

BIOTECH WORK PORTAL
Career Definitions
Labor Market Reports
Education & Training
Regions

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

OncoGenex Pharmaceuticals Inc. 

1522 217th Place SE
Suite 100
Bothell  Washington  98021  U.S.A.
Phone: 425-686-1500 Fax: 425-686-1600


SEARCH JOBS










 Company News
OncoGenex Pharmaceuticals Inc. Reports Third Quarter 2009 Financial Results 11/6/2009 9:49:59 AM    More...
OncoGenex Pharmaceuticals Inc. to Release Third Quarter 2009 Financial Results 11/3/2009 9:31:36 AM    More...
OncoGenex Pharmaceuticals Inc. CEO Named Canada's Pacific Ernst & Young LLP's Entrepreneur Of The Year(R) in the Health Sciences Category 10/9/2009 10:37:34 AM    More...
FDA Grants Additional Fast Track Designation for OncoGenex Pharmaceuticals Inc.'s OGX-011 in Combination with First Line Chemotherapy 10/6/2009 8:04:09 AM    More...
OncoGenex Pharmaceuticals Inc. to Webcast Presentations at September Investor Conferences 9/3/2009 9:05:14 AM    More...
OncoGenex Pharmaceuticals Inc. Expands Clinical Development of OGX-427 with a Phase 1 Clinical Trial in Bladder Cancer 8/13/2009 7:10:16 AM    More...
OncoGenex Pharmaceuticals Inc. Announces Issuance of Key Patent for OGX-011 8/10/2009 8:03:31 AM    More...
OncoGenex Pharmaceuticals Inc. Reports Second Quarter 2009 Financial Results 8/7/2009 8:24:14 AM    More...
OncoGenex Pharmaceuticals Inc., Rising from Obscurity, Scopes Out Partners to Develop Prostate Cancer Drug 8/5/2009 7:53:19 AM    More...
OncoGenex Pharmaceuticals Inc. Completes $9.5 Million Registered Direct Offering 7/24/2009 8:32:37 AM    More...
1234